These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 8607396

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Electrophysiology and long-term efficacy of pentisomide in patients with supraventricular tachycardia.
    Kühlkamp V, Mewis C, Seipel L.
    Int J Cardiol; 1992 Jul; 36(1):69-79. PubMed ID: 1428255
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. [Electrophysiological testing of multiple antiarrhythmic drugs in patients with paroxysmal supraventricular tachycardia after chronic oral administration].
    Nishino T.
    Hokkaido Igaku Zasshi; 1989 Nov; 64(6):738-48. PubMed ID: 2606448
    [Abstract] [Full Text] [Related]

  • 45. [Clinico-electrophysiologic effects of magnesium, especially in supraventricular tachycardia].
    Vester EG.
    Herz; 1997 Jun; 22 Suppl 1():40-50. PubMed ID: 9333591
    [Abstract] [Full Text] [Related]

  • 46. [Evaluation of the anti-arrhythmia effect of intravenous flecainide in supraventricular tachyarrhythmias].
    Garre L, Alvarez A, Cianciulli T, Quiroga J, Califano J, Mautner B.
    Arch Inst Cardiol Mex; 1989 Jun; 59(3):241-4. PubMed ID: 2506843
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Injectable and oral cibenzoline in the treatment of supraventricular tachycardia related to intranodal reentry or accessory atrioventricular conduction pathway].
    Fauchier JP, Rouesnel P, Breuillac JC, Cosnay P, Scheck F, Garnier LF.
    Ann Cardiol Angeiol (Paris); 1994 Apr; 43(4):194-203. PubMed ID: 8024234
    [Abstract] [Full Text] [Related]

  • 52. Sustained intraatrial reentrant tachycardia: clinical, electrocardiographic and electrophysiologic characteristics and long-term follow-up.
    Haines DE, DiMarco JP.
    J Am Coll Cardiol; 1990 May; 15(6):1345-54. PubMed ID: 2329238
    [Abstract] [Full Text] [Related]

  • 53. [Terminating supraventricular tachycardia with adenosine--comparing the effectiveness of 12 mg and 18 mg].
    Weismüller P, Kattenbeck K, Heinroth KM, Ranke C, Trappe HJ.
    Dtsch Med Wochenschr; 2000 Aug 18; 125(33):961-9. PubMed ID: 10994404
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. The safety of flecainide treatment of atrial fibrillation: long-term incidence of sudden cardiac death and proarrhythmic events.
    Almroth H, Andersson T, Fengsrud E, Friberg L, Linde P, Rosenqvist M, Englund A.
    J Intern Med; 2011 Sep 18; 270(3):281-90. PubMed ID: 21635583
    [Abstract] [Full Text] [Related]

  • 56. Sudden death of a horse with supraventricular tachycardia following oral administration of flecainide acetate.
    Dembek KA, Hurcombe SD, Schober KE, Toribio RE.
    J Vet Emerg Crit Care (San Antonio); 2014 Sep 18; 24(6):759-63. PubMed ID: 25388866
    [Abstract] [Full Text] [Related]

  • 57. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study.
    Jaeggi ET, Carvalho JS, De Groot E, Api O, Clur SA, Rammeloo L, McCrindle BW, Ryan G, Manlhiot C, Blom NA.
    Circulation; 2011 Oct 18; 124(16):1747-54. PubMed ID: 21931080
    [Abstract] [Full Text] [Related]

  • 58. Long-term antitachycardia pacing experience for supraventricular tachycardia.
    den Dulk K, Brugada P, Smeets JL, Wellens HJ.
    Pacing Clin Electrophysiol; 1990 Aug 18; 13(8):1020-30. PubMed ID: 1697949
    [Abstract] [Full Text] [Related]

  • 59. [Electrophysiologic effects of intravenous flecainide in intranodal junctional tachycardia in 30 patients].
    Haissaguerre M, Warin JF, Goldrach S, Le Métayer P, Guillem JP, Blanchot P.
    Arch Mal Coeur Vaiss; 1988 Dec 18; 81(12):1493-8. PubMed ID: 3147639
    [Abstract] [Full Text] [Related]

  • 60. Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group.
    Naccarelli GV, Dorian P, Hohnloser SH, Coumel P.
    Am J Cardiol; 1996 Jan 25; 77(3):53A-59A. PubMed ID: 8607392
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.